Pangaea Oncology, S.A. (PANG.MC)

EUR 1.7

(1.19%)

Operating Income Summary of Pangaea Oncology, S.A.

  • Pangaea Oncology, S.A.'s latest annual operating income in 2023 was -3.82 Million EUR , down -212.96% from previous year.
  • Pangaea Oncology, S.A.'s latest quarterly operating income in 2023 FY was -2.89 Million EUR , down -212.96% from previous quarter.
  • Pangaea Oncology, S.A. reported an annual operating income of 2.55 Million EUR in 2022, up 580.05% from previous year.
  • Pangaea Oncology, S.A. reported an annual operating income of -532.96 Thousand EUR in 2021, up 67.98% from previous year.
  • Pangaea Oncology, S.A. reported a quarterly operating income of -558.63 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.
  • Pangaea Oncology, S.A. reported a quarterly operating income of -1.35 Million EUR for 2023 Q3, down -141.96% from previous quarter.

Annual Operating Income Chart of Pangaea Oncology, S.A. (2023 - 2013)

Historical Annual Operating Income of Pangaea Oncology, S.A. (2023 - 2013)

Year Operating Income Operating Income Growth
2023 -3.82 Million EUR -212.96%
2022 2.55 Million EUR 580.05%
2021 -532.96 Thousand EUR 67.98%
2020 -1.66 Million EUR 65.27%
2019 -4.79 Million EUR -168.87%
2018 -1.78 Million EUR 34.19%
2017 -2.7 Million EUR -399.18%
2016 -542.56 Thousand EUR 44.33%
2015 -974.65 Thousand EUR 8.58%
2014 -1.06 Million EUR -607.84%
2013 209.94 Thousand EUR 0.0%

Peer Operating Income Comparison of Pangaea Oncology, S.A.

Name Operating Income Operating Income Difference
Clínica Baviera, S.A. 50.01 Million EUR 107.639%